CNS vs FHI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 17, 2026

CNS

61.5
AI Score
VS
CNS Wins

FHI

61.0
AI Score

Investment Advisor Scores

CNS

62score
Recommendation
BUY

FHI

61score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS FHI Winner
Forward P/E 23.1481 11.3507 FHI
PEG Ratio 1.9142 2.3157 CNS
Revenue Growth 8.3% 13.1% FHI
Earnings Growth 6.5% 1.6% CNS
Tradestie Score 61.5/100 61.0/100 CNS
Profit Margin 27.5% 21.5% CNS
Beta 1.00 1.00 Tie
AI Recommendation BUY BUY Tie

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.